Navigation Links
Levothyroxine Thyroid Hormone Replacement, Approved for Hypothyroidism

The thyroid hormone replacement prescription drug, levothyroxine sodium (Unithroid) for hypothyroidism in adults and children has been approved for use in the United States by the FDA.

The thyroid hormaone is involved in the regulation of a wide range of metabolic processes within the body in all age groups. In children thyroid hormones are essential for normal physical growth and intellectual development.

Low levels of thyroid hormone or hypothyroidism may be due to a birth defect for examole partial or complete absence of the thyroid gland or it may occur later in life due in conditions such as thyroiditis, goiter, or on surgical removal of the thyroid gland.

Other or previously-used medications, such as Synthroid, Cytomel, Euthyroid, Thyrolar, and Armour Thyroid, are often difficult to control, and sometimes results in symptoms of hyperthyroidism.

Levothyroxine sodium (Unithroid) is identical to a natural thyroid hormone produced by the body.

During initiation of replacement therapy with levothyroxine, blood tests are usually performed every six to eight weeks in adults to aid in dose adjustment. Once the optimal replacement dose of levothryoxine for an individual adult patient is determined, blood tests are usually done less frequently; e.g., every six to twelve months.

Symptoms of hypothyroidism include poor growth in children and, in those born with this disorder, impaired intellectual development if this disorder is not promptly and adequately treated. Symptoms of hypothyroidism in children and adults include fatigue, cold intolerance, dry skin, lethargy and weight gain.
'"/>




Page: 1

Related medicine news :

1. Thyroid hormone treatment hastens recovery after cardiac surgery
2. Another Cause of Thyroid Cancer Discovered
3. Common Thyroid Problems In Women May Lower Their Risk Of Developing Breast Cancer
4. Tumour marker for detecting early Recurrence of Thyroid cancer may be soon available
5. Risk of Thyroid cancer is increased after Childhood Irradiation of Neck region
6. Endoscopic Thyroidectomy Helps In Removing Thyroid Cysts
7. Differentiated Thyroid Carcinoma Can Widely Infiltrate The Larynx
8. Chornobyl Incident Proved Increased Risk of Thyroid Cancer from Radioactive Iodine
9. New Study Suggests Perchlorate Effects on Thyroid Function of U.S. Women
10. Levels of Thyroid Hormone Forecasts Life Span
11. Longer-Lived Rodents Have Lower Levels of Thyroid Hormone
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/17/2017)... ... August 17, 2017 , ... Georgia Urology, ... Dr. Kristi Hebert to its newest location in East Cobb (4800 ... Dr. Hebert come aboard,” said Dr. Mark A. Haber, Georgia Urology’s managing partner. “She ...
(Date:8/17/2017)... Houston, Texas (PRWEB) , ... August 17, 2017 ... ... Dr. Rukmini “Vinaya” Rednam distinguishes herself once more by being among Houston’s first ... clientele receives the highest quality plastic surgery care without disrupting busy schedules and ...
(Date:8/17/2017)... ... ... SeQuel Response announced today that for the fourth consecutive year, ... companies in the U.S., putting it in the top 10 percent of applicants nationwide. ... Inc. 5000 over the years, only a fraction have made the list more ...
(Date:8/17/2017)... ... 2017 , ... CareAcademy, a provider of specialized online training ... in seed funding to further expand its course portfolio and increase its market ... the company’s primary investors. , Founded in 2016, CareAcademy currently serves ...
(Date:8/17/2017)... Ca (PRWEB) , ... August 17, 2017 , ... Centrifugation ... useful tools in the laboratory that we can no longer do without. And just ... the lifetime of your device. , In this webinar, attendees will learn about the ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... Second-quarter 2017 revenues of $876 ... from continuing operations Second-quarter ... $110 million Second-quarter 2017 ... Second-quarter 2017 adjusted diluted ... percent to $0.93 Second-quarter ...
(Date:8/7/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) today ... effective Aug. 7, 2017. ... interests and will serve as president emeritus during a planned, ... in multiple leadership roles since he joined Diplomat with the ... provided decisive, strategic leadership which continues to benefit our patients ...
(Date:8/4/2017)... , Aug. 4, 2017 The search ... shortly after a physician/patient consult has long been the ... was a notable focus of the largest meeting of ... according to healthcare market research firm Kalorama Information.  The ... testing (POCT) offerings or related supplies and software were ...
Breaking Medicine Technology: